| ↑ | upregulation |
| ↓ | downregulation |
| ✓ | Condition occurring |
| 2D | Two-dimensional |
| 3D | Three-dimensional |
| ALP | Alkaline phosphatase |
| Bio-P3 | Bio-Pick, Place, and Perfuse |
| BM-MSCs | Bone marrow-derived mesenchymal stem cells |
| CL | Crypt-like |
| CNS | Central nervous system |
| CSC | Cancer stem cell |
| CVS | Cardiovascular system |
| ECM | Extracellular matrix |
| EMT | Epithelial–mesenchymal transition |
| bFGF | Basic fibroblast growth factor |
| HCC | Hepatocellular carcinoma |
| hESC | Human embryonic stem cells |
| HIF-α | Hypoxia-inducible factor-1-alpha |
| hiPSCs | Human induced pluripotent stem cells |
| HSC | Hematopoietic stem cells |
| hSIOs | Human small intestinal organoids |
| HSPCs | Hematopoietic stem/progenitor cells |
| iHeps | iPSC-derived human hepatocyte-like cells |
| IR | Ischemia–reperfusion |
| MSCs | Mesenchymal stem cells |
| OBs | Osteoblasts |
| PDAC | Pancreatic ductal adenocarcinoma |
| PDGF | Platelet-derived growth factor |
| PO2 | Partial oxygen pressure |
| STAMP | Spheroid transfer assisted by magnetic printing |
| SWIFT | Sacrificial writing into functional tissues |
| TGF-β | Transforming growth factor-beta |
| TME | Tumor microenvironment |
| VEGF | Vascular endothelial growth factor |
| VL | Villus-like |
| vMPS | Vascularized microphysiological systems |
| VNQI | Vascular network quality index |